Paper42100367
Translational insights into miR-126 and miR-423: biomarkers and therapeutic targets in cancer, cardiovascular, metabolic and kidney diseases.
Rodzoń-Norwicz M. Front Mol Biosci, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Translational insights into miR-126 and miR-423: biomarkers and therapeutic targets in cancer, cardiovascular, metabolic and kidney diseases. Papers, record 42100367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42100367
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Translational insights into miR-126 and miR-423: biomarkers and therapeutic targets in cancer, cardiovascular, metabolic and kidney diseases.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References92
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33785398 | Micro-RNA: The darkhorse of cancer. | Cell Signal | 2021 | https://conductscience.org/library/papers/33785398 | PubMed |
| 2 | 35322532 | miR-126-5p enhances radiosensitivity of lung adenocarcinoma cells by inhibiting EZH2 via the KLF2/BIRC axis. | J Cell Mol Med | 2022 | https://conductscience.org/library/papers/35322532 | PubMed |
| 3 | 36376958 | Roles of physical exercise-induced MiR-126 in cardiovascular health of type 2 diabetes. | Diabetol Metab Syndr | 2022 | https://conductscience.org/library/papers/36376958 | PubMed |
| 4 | 41270025 | Circulating microRNAs as biomarkers for diabetic retinopathy stage identification: A DTA systematic review and meta-analysis. | PLoS One | 2025 | https://conductscience.org/library/papers/41270025 | PubMed |
| 5 | 38445462 | Methylation Status of miR-34a and miR-126 in Non-Small Cell Lung Cancer (NSCLC) Tumor Tissues. | Iran Biomed J | 2024 | https://conductscience.org/library/papers/38445462 | PubMed |
| 6 | 38469304 | MicroRNA-126 selected with broad-spectrum analysis of microRNAs - a new predictive factor for the effectiveness of immunotherapy or chemoimmunotherapy in advanced NSCLC patients? | Front Immunol | 2024 | https://conductscience.org/library/papers/38469304 | PubMed |
| 7 | 36756041 | Effects of Intensive Glycemic Control on Serum Exosome miR-126-3p and miR-125b-1-3p Levels and Wound Healing in Patients with Diabetic Ulcers. | Evid Based Complement Alternat Med | 2023 | https://conductscience.org/library/papers/36756041 | PubMed |
| 8 | 39702526 | The biogenesis and regulation of animal microRNAs. | Nat Rev Mol Cell Biol | 2025 | https://conductscience.org/library/papers/39702526 | PubMed |
| 9 | 30423142 | miRBase: from microRNA sequences to function. | Nucleic Acids Res | 2019 | https://conductscience.org/library/papers/30423142 | PubMed |
| 10 | 40388304 | MicroRNAs and vascular damage in chronic kidney disease: advances and clinical implications. | J Bras Nefrol | 2025 | https://conductscience.org/library/papers/40388304 | PubMed |
| 11 | 32410348 | miR-126 reduces trastuzumab resistance by targeting PIK3R2 and regulating AKT/mTOR pathway in breast cancer cells. | J Cell Mol Med | 2020 | https://conductscience.org/library/papers/32410348 | PubMed |
| 12 | 39478171 | MiR-126 accelerates renal injury induced by UUO via inhibition PI3K/ IRS-1/ FAK signaling induced M2 polarization and endocytosis in macrophages. | Sci Rep | 2024 | https://conductscience.org/library/papers/39478171 | PubMed |
| 13 | 35328298 | miR-126 Decreases Proliferation and Mammosphere Formation of MCF-7 and Predicts Prognosis of ER+ Breast Cancer. | Diagnostics (Basel) | 2022 | https://conductscience.org/library/papers/35328298 | PubMed |
| 14 | 34017372 | Protective mechanism of apigenin in diabetic nephropathy is related to its regulation of miR-423-5P-USF2 axis. | Am J Transl Res | 2021 | https://conductscience.org/library/papers/34017372 | PubMed |
| 15 | 36675311 | MicroRNAs Associated with Chronic Kidney Disease in the General Population and High-Risk Subgroups-A Systematic Review. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36675311 | PubMed |
| 16 | 10706289 | The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. | Nature | 2000 | https://conductscience.org/library/papers/10706289 | PubMed |
| 17 | 41516293 | miRNA in the Progression of Diabetic Kidney Disease: New Insight. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41516293 | PubMed |
| 18 | 35153496 | Decreased Levels of miR-126 and miR-132 in Plasma and Vitreous Humor of Non-Proliferative Diabetic Retinopathy Among Subjects with Type-2 Diabetes Mellitus. | Diabetes Metab Syndr Obes | 2022 | https://conductscience.org/library/papers/35153496 | PubMed |
| 19 | 35363937 | miR-126 downregulates CXCL12 expression in intestinal epithelial cells to suppress the recruitment and function of macrophages and tumorigenesis in a murine model of colitis-associated colorectal cancer. | Mol Oncol | 2022 | https://conductscience.org/library/papers/35363937 | PubMed |
| 20 | 34117709 | miR-126-3p is essential for CXCL12-induced angiogenesis. | J Cell Mol Med | 2021 | https://conductscience.org/library/papers/34117709 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42509801 | The Inflammaging-Redox-InflammamiR Axis in Metabolic Aging: From Diagnostic Clusters to Integrated Risk Phenotypes. | Biomolecules | 2026 | https://conductscience.org/library/papers/42509801 |
Source PubMed
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| MIR126 | 406913 | PubTator's text mining | https://conductscience.org/library/genes/406913 | NCBI Gene |
| MIR1263 | 100302148 | PubTator's text mining | https://conductscience.org/library/genes/100302148 | NCBI Gene |
| MIR1265 | 100302116 | PubTator's text mining | https://conductscience.org/library/genes/100302116 | NCBI Gene |
| MIR423 | 494335 | PubTator's text mining | https://conductscience.org/library/genes/494335 | NCBI Gene |
| PIK3CB | 5291 | PubTator's text mining | https://conductscience.org/library/genes/5291 | NCBI Gene |
| PTK2B | 2185 | PubTator's text mining | https://conductscience.org/library/genes/2185 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42100367
GET https://conductscience.org/api/papers/v1/42100367/references?page=2